Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sandra Zanger"'
Autor:
Joana Grand-Guillaume, Rosalba Mansi, Raghuvir H. Gaonkar, Sandra Zanger, Melpomeni Fani, Philippe J. Eugster, Maja Beck Popovic, Eric Grouzmann, Karim Abid
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-20 (2023)
Abstract Background Neuroblastoma (NB) and pheochromocytoma/paraganglioma (PHEO/PGL) are neuroendocrine tumors. Imaging of these neoplasms is performed by scintigraphy after injection of radiolabeled meta-iodobenzylguanidine (mIBG), a norepinephrine
Externí odkaz:
https://doaj.org/article/d02749981c7d40669065e704f066964b
Autor:
Raghuvir Haridas Gaonkar, Fabius Wiesmann, Luigi Del Pozzo, Lisa McDougall, Sandra Zanger, Renata Mikołajczak, Rosalba Mansi, Melpomeni Fani
Publikováno v:
Pharmaceuticals, Vol 14, Iss 4, p 300 (2021)
[99mTc]Tc-HYNIC-TOC is the most widely used 99mTc-labeled somatostatin receptor (SST) agonist for the SPECT imaging of SST-expressing tumors, such as neuroendocrine tumors. Recently, radiolabeled SST antagonists have shown improved diagnostic efficac
Externí odkaz:
https://doaj.org/article/d088fb8cab9d4527b2cdcc898340a4b5
Autor:
Renata Mikolajczak, Rosalba Mansi, Lisa McDougall, Luigi Del Pozzo, Raghuvir Haridas Gaonkar, Fabius Wiesmann, Sandra Zanger, Melpomeni Fani
Publikováno v:
Pharmaceuticals, Vol 14, Iss 300, p 300 (2021)
Pharmaceuticals
Volume 14
Issue 4
Pharmaceuticals
Volume 14
Issue 4
[99mTc]Tc-HYNIC-TOC is the most widely used 99mTc-labeled somatostatin receptor (SST) agonist for the SPECT imaging of SST-expressing tumors, such as neuroendocrine tumors. Recently, radiolabeled SST antagonists have shown improved diagnostic efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b030d8363d59da15717a0ae9e9c818dc
https://www.mdpi.com/1424-8247/14/4/300
https://www.mdpi.com/1424-8247/14/4/300